The authors also emphasize that after stimulation with TLR ligands, CD80 and CD86 expression on innate cells was not changed in patients with CVID, although three patients showed low baseline levels of these surface molecules on monocytes compared to healthy controls. The gene discussed is CD86; the disease is common variable immunodeficiency.